LH

SEC source: 0001127602-25-003720 · form4.xml · nonDerivative · entry 1

Caveney Brian J · CIK 0001717915 · EVP, Pres of ED, CMO & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,763.6573

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

F2 · balance_after: Amount includes 93.8655 shares acquired on June 30, 2024 and 16.6340 shares acquired on December 31, 2024 under the Labcorp Holdings Inc. Amended and Restated 2016 Employee Stock Purchase Plan.

SEC source: 0001127602-25-003719 · form4.xml · derivative · entry 7

Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,337

Underlying: Common Stock · 180 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-25-003719 · form4.xml · nonDerivative · entry 2

Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 546

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-25-003719 · form4.xml · nonDerivative · entry 1

Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 616

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

SEC source: 0001127602-25-003718 · form4.xml · derivative · entry 5

Oyegunwa Akinbolade · CIK 0002042869 · EVP, CIO & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,902

Underlying: Common Stock · 180 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-25-003718 · form4.xml · nonDerivative · entry 2

Oyegunwa Akinbolade · CIK 0002042869 · EVP, CIO & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,784.253

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-25-003718 · form4.xml · nonDerivative · entry 1

Oyegunwa Akinbolade · CIK 0002042869 · EVP, CIO & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,846.253

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

SEC source: 0001127602-25-003717 · form4.xml · derivative · entry 5

Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,094

Underlying: Common Stock · 223 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-25-003717 · form4.xml · nonDerivative · entry 2

Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,468.5

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-25-003717 · form4.xml · nonDerivative · entry 1

Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,541.5

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

SEC source: 0001127602-25-003716 · form4.xml · derivative · entry 7

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,322

Underlying: Common Stock · 743 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-25-003716 · form4.xml · nonDerivative · entry 2

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,569.1426

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-25-003716 · form4.xml · nonDerivative · entry 1

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,779.1426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

SEC source: 0001127602-25-003715 · form4.xml · derivative · entry 5

Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 658

Underlying: Common Stock · 133 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-25-003715 · form4.xml · nonDerivative · entry 2

Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,174.2194

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-25-003715 · form4.xml · nonDerivative · entry 1

Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,220.2194

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

SEC source: 0001127602-25-003714 · form4.xml · derivative · entry 5

Schechter Adam H · CIK 0001376841 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,382

Underlying: Common Stock · 4,460 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Common Inc. Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-25-003714 · form4.xml · nonDerivative · entry 2

Schechter Adam H · CIK 0001376841 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,661

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-25-003714 · form4.xml · nonDerivative · entry 1

Schechter Adam H · CIK 0001376841 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,901

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Common Inc. Stock.

SEC source: 0001127602-25-003713 · form4.xml · derivative · entry 5

van der Vaart Sandra D · CIK 0001537208 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,804

Underlying: Common Stock · 386 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F4 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-25-003713 · form4.xml · nonDerivative · entry 2

van der Vaart Sandra D · CIK 0001537208 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,987.5397

F3 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-25-003713 · form4.xml · nonDerivative · entry 1

van der Vaart Sandra D · CIK 0001537208 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,089.5397

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F2 · balance_after: Amount includes 33.6927 shares acquired on December 31, 2024 under the Labcorp Holdings Inc. Amended and Restated 2016 Employee Stock Purchase Plan.

SEC source: 0001127602-25-003712 · form4.xml · derivative · entry 5

GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,390

Underlying: Common Stock · 326 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-25-003712 · form4.xml · nonDerivative · entry 2

GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-25-003712 · form4.xml · nonDerivative · entry 1

GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 618

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

SEC source: 0001127602-25-003711 · form4.xml · derivative · entry 3

Wang Julia Aijun · CIK 0001860279 · Chief Financial Officer, EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,787

Underlying: Common Stock · 893 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-25-003711 · form4.xml · nonDerivative · entry 2

Wang Julia Aijun · CIK 0001860279 · Chief Financial Officer, EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 557

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-25-003711 · form4.xml · nonDerivative · entry 1

Wang Julia Aijun · CIK 0001860279 · Chief Financial Officer, EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 893

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

SEC source: 0001127602-25-003710 · form4.xml · derivative · entry 2

Wengel Kathryn E · CIK 0001745955 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 944 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 6, 2025.

F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 6, 2025.

SEC source: 0001127602-25-003710 · form4.xml · nonDerivative · entry 1

Wengel Kathryn E · CIK 0001745955 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,236

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

SEC source: 0001127602-25-003708 · form4.xml · derivative · entry 2

NEUPERT PETER M · CIK 0001237566 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 944 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 6, 2025.

F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 6, 2025.

SEC source: 0001127602-25-003708 · form4.xml · nonDerivative · entry 1

NEUPERT PETER M · CIK 0001237566 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,887

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

SEC source: 0001127602-25-003709 · form4.xml · derivative · entry 2

Parham Richelle P · CIK 0001550078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 944 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 6, 2025.

F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 6, 2025.

SEC source: 0001127602-25-003709 · form4.xml · nonDerivative · entry 1

Parham Richelle P · CIK 0001550078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,478

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

SEC source: 0001127602-25-003707 · form4.xml · derivative · entry 2

Kong Garheng · CIK 0001435183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 944 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 6, 2025.

F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 6, 2025.

SEC source: 0001127602-25-003707 · form4.xml · nonDerivative · entry 1

Kong Garheng · CIK 0001435183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,842

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

SEC source: 0001127602-25-003705 · form4.xml · derivative · entry 2

Davis Jeffrey A. · CIK 0001648477 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 944 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 6, 2025.

F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 6, 2025.

SEC source: 0001127602-25-003705 · form4.xml · nonDerivative · entry 1

Davis Jeffrey A. · CIK 0001648477 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,563

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

SEC source: 0001127602-25-003704 · form4.xml · derivative · entry 2

Kliphouse Kirsten Marie · CIK 0001948684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 944 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 6, 2025.

F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 6, 2025.

SEC source: 0001127602-25-003704 · form4.xml · nonDerivative · entry 1

Kliphouse Kirsten Marie · CIK 0001948684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,263

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

SEC source: 0001127602-25-003702 · form4.xml · derivative · entry 4

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 944 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 6, 2025.

F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 6, 2025.

SEC source: 0001127602-25-003702 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

SEC source: 0001127602-25-003700 · form4.xml · derivative · entry 2

Rothman Paul · CIK 0001601332 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 944 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units vested fully on February 6, 2025.

F3 · derivative.expiration_date: The Restricted Stock Units vested fully on February 6, 2025.

SEC source: 0001127602-25-003700 · form4.xml · nonDerivative · entry 1

Rothman Paul · CIK 0001601332 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,674

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F2 · balance_after: Amount includes 13 shares previously reported on the reporting person's Form 3 filed on June 7, 2023 that were inadvertently omitted from the reporting person's Form 4 filed on June 10, 2024.

SEC source: 0001127602-25-003697 · form4.xml · derivative · entry 2

Gilliland Dwight Gary · CIK 0001603769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 944 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 6, 2025.

F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 6, 2025.

SEC source: 0001127602-25-003697 · form4.xml · nonDerivative · entry 1

Gilliland Dwight Gary · CIK 0001603769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,656

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

SEC source: 0001127602-25-000986 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,722

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

SEC source: 0001127602-24-028581 · form4.xml · derivative · entry 2

Wang Julia Aijun · CIK 0001860279 · Chief Financial Officer, EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,680

Underlying: Common Stock · 2,680 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 6, 2025.

F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 6, 2025.

SEC source: 0001127602-24-028581 · form4.xml · derivative · entry 1

Wang Julia Aijun · CIK 0001860279 · Chief Financial Officer, EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,100

Underlying: Common Stock · 8,100 shares

Expires 2034-12-01

F1 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.

F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column.

SEC source: 0001127602-24-028580 · form4.xml · derivative · entry 5

EISENBERG GLENN A · CIK 0001222831 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,577

Underlying: Common Stock · 2,788 shares

Expires 2033-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.

F3 · derivative.exercise_price: Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("LHI"), calculated pursuant to the terms of the Employee Matters Agreement by and between LHI and Fortrea.

F3 · shares: Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("LHI"), calculated pursuant to the terms of the Employee Matters Agreement by and between LHI and Fortrea.

F5 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column.